Table 7.
Clinicopathologic factors predicating the prognosis in multivariate Cox regression models.
| Patient Characteristics | HR | 95% CI | P a |
|---|---|---|---|
| Age, >55 vs. <55 yr | 0.89 | 0.45–1.76 | 0.743 |
| AJCC Stage | 0.065 | ||
| I | 1.00 | ||
| II | 1.05 | 0.42–2.60 | |
| III | 1.58 | 0.51–4.91 | |
| IV | 2.97 | 1.16–7.61 | |
| Treatment | 0.002 | ||
| Chemo | 1.00 | ||
| None | 1.79 | 0.92–3.49 | |
| Neoadjuvant, surgery | 0.29 | 0.12–0.70 | |
| Surgery only | 0.60 | 0.22–1.64 | |
| Surgery, adjuvant | 0.51 | 0.15–1.73 | |
| Neoadjuvant, surgery, adjuvant | 0.12 | 0.02–0.59 | |
| COX-2, low vs. high | 0.89 | 0.45–1.76 | 0.743 |
a Bold type indicates statistical significance (p < 0.05). Abbreviations: HR, Hazard ratio; CI, Confidence interval; AJCC, American Joint Committee on Cancer; COX-2 cyclooxygenase 2.